Medical Letter on the CDC and FDA

American College for Advancement in Medicine - ACAM Affirms Commitment to Trial to Assess Chelation Therapy

Analgesics - QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy

Aurora Imaging Technology Inc. - Aurora Dedicated Breast MRI Now Available at the Comprehensive Breast Center of the Don and Sybil Harrington Cancer Center

Biotechnology Business - Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.

Biotechnology Industry Organization - BIO Lauds Senate for FDA and NIH Funding Boosts

Bone Research - Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries

Breast Cancer - First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

Breast Cancer - TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)

Cancer - GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)

Cancer International Research Group - First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin TCH for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

China Biologic Products, Inc. - China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)

Chrysler Canada - Ontario Ministry of Health and Long-Term Care Announces Chrysler Minivan Purchase

Clinical Trial Research - Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial

Clinical Trial Research - Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders

Collagen Matrix, Inc. - Collagen Matrix, Inc. Receives FDA 510k Clearance for TenoMend Collagen Tendon Wrap for the Management and Protection of Tendon Injuries

Colon Cancer - New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

Constipation - Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation

Cook Medical - Cook Medical Receives FDA Approval for Advanced Thoracic Aortic Aneurysm Endovascular Graft

Diabetes - International Diabetes Federation Grant Supports Jordanian Diabetes Micro-Clinic Program

ExL Pharma - FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - the

Irritable Bowel Syndrome - AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

LDR - LDR Announces Release of its ROI-T Transforaminal Approach Implant

Lupin Pharmaceuticals, Inc. - Lupin Receives USFDA Approval for Topiramate Tablets

Marketing and Licensing Agreements - AlphaRx Signs Cooperative Research and Development Agreement with US Army

Mental Health - The MOTHERS Act: Thalidomide Revisited?

Movetis - Movetis Files RESOLOR With EMEA for the Indication of Chronic Constipation

National Instruments - National Instruments Advances Medical Device Design with Technology and Training

Osmotica Pharmaceutical Corp. - Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl

PBM Holdings, Inc. - PBM Companies Partner with the Red Cross to Donate Infant Formula to China Earthquake Victims

Poisoning - Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning

Regulatory Actions - Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies

Santarus, Inc. - Santarus Achieves $2.5 Million Regulatory Milestone under OTC License Agreement with Schering-Plough

Santarus, Inc. - Santarus Announces Development Program for New ZEGERID Prescription Product

Solid Cancer - FASgen Diagnostics, LLC Announces Production and Investment Agreement With Tetracore, Inc.

Somanetics Corporation - Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling

StemCells, Inc. - StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease

Takeda Pharmaceuticals North America, Inc.; Sucampo Pharmaceuticals - AMITIZA lubiprostone 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

University of Oklahoma - New treatment for hepatitis C

Vaccines - Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims